Borovcanin Milica M,Vesic Katarina,Petrovic Ivica R,Jovanovic Ivan P,Mijailovic Natasa R (2023) Diabetes mellitus type 2 as an underlying, comorbid or consequent state of mental disorders, WORLD JOURNAL OF DIABETES, vol. 14, br. 5, str. 481-493 (Review) 

Vesic Katarina,Gavrilovic Aleksandar,Mijailovic Natasa R,Borovcanin Milica M (2023) Neuroimmune, clinical and treatment challenges in multiple sclerosis-related psychoses, WORLD JOURNAL OF PSYCHIATRY, vol. 13, br. 4, str. 161-170 (Review) 

Borovcanin Milica M,Vesic Katarina,Arsenijevic Dragana,Milojevic-Rakic Maja,Mijailovic Natasa R,Jovanovic Ivan P (2023) Targeting Underlying Inflammation in Carcinoma Is Essential for the Resolution of Depressiveness, CELLS, vol. 12, br. 5, str. - (Review) 

Minic-Janicijevic Slavica,Jovanovic Ivan P,Gajovic Nevena M,Jurisevic Milena M,Debnath Monojit,Arsenijevic Nebojsa N,Borovcanin Milica M (2022) Galectin-3 mediated risk of inflammation in stable schizophrenia, with only possible secondary consequences for cognition, WORLD JOURNAL OF PSYCHIATRY, vol. 12, br. 9, str. 1183-1193 (Article) 

Mijailovic Natasa R,Vesic Katarina,Arsenijevic Dragana,Milojevic-Rakic Maja,Borovcanin Milica M (2022) Galectin-3 Involvement in Cognitive Processes for New Therapeutic Considerations, FRONTIERS IN CELLULAR NEUROSCIENCE, vol. 16, br. , str. - (Review) 

Borovcanin Milica M,Minic-Janicijevic Slavica,Mijailovic Natasa R,Jovanovic Ivan P,Arsenijevic Nebojsa N,Vesic Katarina (2022) Uric Acid Potential Role in Systemic Inflammation and Negative Symptoms After Acute Antipsychotic Treatment in Schizophrenia, FRONTIERS IN PSYCHIATRY, vol. 12, br. , str. - (Article) 

Borovcanin Milica M,Vesic Katarina (2021) Breast cancer in schizophrenia could be interleukin-33-mediated, WORLD JOURNAL OF PSYCHIATRY, vol. 11, br. 11, str. 1065-1074 (Review) 

Borovcanin Milica M,Vesic Katarina,Jovanovic Milena,Mijailovic Natasa R (2021) Galectin-3 possible involvement in antipsychotic-induced metabolic changes of schizophrenia: A minireview, WORLD JOURNAL OF DIABETES, vol. 12, br. 10, str. 1731-1739 (Review) 

Borovcanin Milica M,Radosavljevic Gordana D,Pantic Jelena M,Milovanovic Jelena Z,Mijailovic Natasa R,Arsenijevic Aleksandar N,Arsenijevic Nebojsa N (2021) Contrasting Roles of the Galectin-3 in the Schizophrenia Onset, Clinical Presentation, and Somatic Comorbidity, CURRENT TOPICS IN MEDICINAL CHEMISTRY, vol. 21, br. 16, str. 1471-1487 (Review) 

Orsolini Laura,...,Borovcanin Milica M,...,(broj koautora 23) (2021) Psychiatry Trainees' Attitudes, Knowledge, and Training in Addiction Psychiatry-A European Survey, FRONTIERS IN PSYCHIATRY, vol. 11, br. , str. - (Article) 

Borovcanin Milica M,Minic-Janicijevic Slavica,Jovanovic Ivan P,Gajovic Nevena M,Jurisevic Milena M,Arsenijevic Nebojsa N (2020) Type 17 Immune Response Facilitates Progression of Inflammation and Correlates with Cognition in Stable Schizophrenia, DIAGNOSTICS, vol. 10, br. 11, str. - (Article) 

Vesic Katarina,Toncev Gordana L,Drakulic-Miletic Svetlana,Borovcanin Milica M (2020) Oxidative stress and neuroinflammation should be both considered in the occurrence of fatigue and depression in multiple sclerosis, ACTA NEUROLOGICA BELGICA, vol. 120, br. 4, str. 853-861 (Article) 

Borovcanin Nemanja M,Ristanovic Elizabeta S,Todorovic Milena R,Borovcanin Milica M,Jovanovic Mirjana R,Balint Bela J (2019) The use of complementary serological and molecular testing for blood-borne pathogens and evaluation of socio-demographic characteristics of intravenous drug users on substitution therapy from Sumadia district of Serbia, VOJNOSANITETSKI PREGLED, vol. 76, br. 6, str. 587-592 (Article) 

Borovcanin Milica M,Janicijevic Slavica M,Jovanovic Ivan P,Gajovic Nevena M,Arsenijevic Nebojsa N,Lukic Miodrag L (2018) IL-33/ST2 Pathway and Galectin-3 as a New Analytes in Pathogenesis and Cardiometabolic Risk Evaluation in Psychosis, FRONTIERS IN PSYCHIATRY, vol. 9, br. , str. - (Article) 

Curcic Djordje,Stojmenovic Tamara B,Djukic-Dejanovic Slavica M,Dikic Nenad V,Vukasinovic-Vesic Milica Dj,Radivojevic Nenad J,Andjelkovic Marija S,Borovcanin Milica M,Djokic Gorica M (2017) Positive Impact of Prescribed Physical Activity on Symptoms of Schizophrenia: Randomized Clinical Trial, PSYCHIATRIA DANUBINA, vol. 29, br. 4, str. 459-465 (Article) 

Borovcanin Milica M,Jovanovic Ivan P,Radosavljevic Gordana D,Pantic Jelena M,Minic-Janicijevic Slavica,Arsenijevic Nebojsa N,Lukic Miodrag L (2017) Interleukin-6 in Schizophrenia - Is There a Therapeutic Relevance?, FRONTIERS IN PSYCHIATRY, vol. 8, br. , str. - (Review) 

Samardzic Janko S,Borovcanin Milica M,Djukic-Dejanovic Slavica M,Jancic Jasna B,Djuric Milos B,Obradovic Dragan I (2017) In vivo methodology in behavioural pharmacology - Where are we now?, VOJNOSANITETSKI PREGLED, vol. 74, br. 4, str. 354-360 (Review) 

Stefanovic Vesna,Mihajlovic Goran S,Nenadovic Milutin M,Djukic-Dejanovic Slavica M,Borovcanin Milica M,Trajkovic Goran Z (2015) The effect of antipsychotic drugs on nonspecific inflammation markers in the first episode of schizophrenia, VOJNOSANITETSKI PREGLED, vol. 72, br. 12, str. 1085-1092 (Article) 

Borovcanin Milica M,Jovanovic Ivan P,Djukic-Dejanovic Slavica M,Radosavljevic Gordana D,Arsenijevic Nebojsa N,Lukic Miodrag L (2015) Increase systemic levels of IL-23 as a possible constitutive marker in schizophrenia, PSYCHONEUROENDOCRINOLOGY, vol. 56, br. , str. 143-147 (Article) 

Borovcanin Milica M,Jovanovic Ivan P,Radosavljevic Gordana D,Djukic-Dejanovic Slavica M,Stefanovic Vesna,Arsenijevic Nebojsa N,Lukic Miodrag L (2013) Antipsychotics can modulate the cytokine profile in schizophrenia: Attenuation of the type-2 inflammatory response, SCHIZOPHRENIA RESEARCH, vol. 147, br. 1, str. 103-109 (Article) 

Borovcanin Milica M,Jovanovic Ivan P,Radosavljevic Gordana D,Djukic-Dejanovic Slavica M,Bankovic Dragic D,Arsenijevic Nebojsa N,Lukic Miodrag L (2012) Elevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapse, JOURNAL OF PSYCHIATRIC RESEARCH, vol. 46, br. 11, str. 1421-1426 (Article)